Astellas.com - SEO Checker

Sign up for free! PDF Export
Overview of the SEO Check
Meta information
75% 
Page quality
79% 
Page structure
79% 
Link structure
85% 
Server
95% 
External factors
100% 
SEO Score
Response time
1.86 s
File size
84.90 kB
Words
1056
Media files
18
Number of links
203 internal / 4 external

Task list of SEO Improvements

Meta specifications

Title
(Critically important)
Astellas Home page | Astellas Pharma Inc.
The length of the page title is perfect. (383 pixels out of 580 max pixel length)
There are no duplicate words in the title
Meta description
(Critically important)
Astellas Pharma Inc., based in Tokyo, Japan, is a company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products.
The meta description is too long: 1192 pixels from max. 1000 pixels. Optimize description
Crawlability
(Critically important)
There are no problems in accessing the website.
Canonical URL
(Important)
https://www.astellas.com/en
The specified canonical link points to a different page.
Language
(Somewhat important)
Language detected in text: en
Language defined in HTML: en
Server location: United States of America
The following language is defined by HTML: en
Alternate/Hreflang Links
(Somewhat important)
The specified alternate links have no errors.
Other meta tags
(Somewhat important)
There is no rel next meta tag on this page.
There is no rel prev meta tag on this page.
Domain
(Somewhat important)
The domain is no subdomain.
The domain length is good.
The domain does not contain non-latin characters.
Page URL
(Somewhat important)
No parameters were found in the URL.
No session ID was found in the URL.
The URL does not have too many subdirectories.
Charset encoding
(Somewhat important)
The charset encoding (UTF-8) is set correctly.
Doctype
(Nice to have)
The doctype HTML 5 is set correctly.
The doctype is placed at first in the HTML code.
Favicon
(Nice to have)
The favicon is linked correctly.

Meta tags

NameValue
descriptionAstellas Pharma Inc., based in Tokyo, Japan, is a company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products.
thumbnailhttps://www.astellas.com/en/jp/sites/all/themes/astellas/logo.svg
GeneratorDrupal 10 (https://www.drupal.org)
MobileOptimizedwidth
HandheldFriendlytrue
viewportwidth=device-width, initial-scale=1.0
langen
twitter:cardsummary_large_image
twitter:titleTOP
twitter:imagehttps://www.astellas.com/en/sites/all/themes/astellas/astellas_logo_1200-630.jpg
og:titleAstellas Home page | Astellas Pharma Inc.
og:descriptionAstellas Pharma Inc., based in Tokyo, Japan, is a company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products.
og:imagehttps://www.astellas.com/en/sites/all/themes/astellas/astellas_logo_1200-630.jpg
charsetutf-8

Test up to 1.000 webpages of astellas.com with our free plan!

Try For Free
No trial. It's just free!

Page quality

Content
(Critically important)
Some words from the page title are not used within the pages content
This page contains 1056 words. That's ok.
24% of the text are stop words.
The page contains a listing, which indicates a good text layout.
11 paragraphs were found on this page.
No placeholders texts or images were found.
There are no duplicates on the site.
The average number of words per sentence of 18.5 words is good.
Frames
(Critically important)
This page does not use a frameset.
Mobile optimization
(Somewhat important)
No Apple touch icon is specified.
A viewport "width=device-width, initial-scale=1.0" is provided.
Bold and strong tags
(Somewhat important)
The usage of strong and bold tags is perfect. We recommend the use of up to 21 tags for this page.
Image SEO
(Somewhat important)
Alt text (alternative text) is correctly used on all found images.
Social Networks
(Nice to have)
There are only a few social sharing widgets on the page. Make your website popular in social networks with social sharing widgets.
Additional markup
(Nice to have)
No additional page markup was found.
HTTPS
(Somewhat important)
This website uses HTTPS to protect privacy and integrity of the exchanged data.
All included files are also transferred via HTTPS.

Media list

URLAlt attributeTitle
/themes/custom/astellas_v2/logo.svgAstellas Pharma Inc.Astellas Pharma Inc.
/sites/all/themes/astellas/logo.svglogo
...er_Integrated-Report-2024_1920x523px.pngIntegrated Report 2024
...der_Integrated-Report-2024_960x540px.pngIntegrated Report 2024
...image/2024-10/Story_960-540px_topics.jpgLeading the Charge in Oncology
..._banner_image/2024-10/600_300_topics.jpgFinancial Results for Q1/FY2024
...er_image/2023-05/From the CEO_600300.pngFrom the CEO
...lated_banner_image/2022-10/top_about.pngAbout us
...ted_banner_image/2022-10/top_r-and-d.pngR & D Strategy
...ner_image/2022-10/top_sustainability.pngAstellas and Sustainability
...mage/2022-10/top_partnering_20221017.pngPartnering with Astellas
...mage/2022-10/top_partnering_20221017.pngPartnering with Astellas
...sub_menu_image/2022-10/top_investors.pngInvestor Relations
.../sub_menu_image/2022-10/top_linkedin.pngLinkedIn
...ll/themes/astellas/images/logo_white.svgfooter logo
...all/themes/astellas/images/solgan_en.svgfooter solgan
...les/bxbito15231/files/linkedin_small.pngLinkedin Logo
...les/bxbito15231/files/youtube_footer.pngYoutube Logo

Page structure

H1 heading
(Critically important)
There is no H1 heading specified.
Headings
(Important)
The structure of headings is missing one or more levels. Do not skip heading levels.

Heading structure

Heading levelContent
H2 Stakeholders menu
H2 Common header menu
H2 Integrated Report 2024
H2 Leading the Charge in Oncology
H2 Financial Results for Q1/FY2024
H2 From the CEO
H2 About us
H2 R & D Strategy
H2 Sustainability
H2 Partnering with Astellas
H2 Investor Relations
H2 Astellas Pharma’s official LinkedIn
H2 Modern Slavery Act 2015
H2 Contact for Potential Acquisition of Astellas’ R＆D programs.
H2 Bottom footer menu
Some internal link anchor texts are too long.
Some anchor texts are used more than once.
The number of internal links is ok.
All internal links are not using dynamic parameters.
There are 4 external links on this page.

Found links on this page

LinkAttributesAnchor text
https://www.astellas.com/enIMG-ALT Astellas Pharma Inc.
https://www.astellas.com/en/aboutAbout
/en/investors/strategic-planCorporate Strategic Plan 2021 Corporate Strategic Plan 2021 (CSP2021) maps the next five years of our journey. Read More
/en/about/messageFrom the CEO
/en/about/philosophyPhilosophy
/en/about/charter-of-corporate...Astellas Charter of Corporate Conduct, Group Code of Conduct
/en/about/visionVISION
/en/about/corporate-informationAt a Glance
/en/about/subsidiaries-and-loc...Subsidiaries & Locations
/en/about/our-businessOur Business
/en/about/main-productsMain Products
/en/about/historyHistory
/en/about/managementManagement
/en/about/board-of-directorsBoard of Directors
/en/about/top-managementGlobal Management Structure
/en/about/governanceCorporate Governance Materials
/en/about/risk-managementRisk Management
/en/about/policies-and-positio...Policies & Position Statements
/en/about/ethics-complianceEthics & Compliance
/en/about/structure-to-promoteStructure to Promote Ethics and Compliance
/en/about/primary-areas-of-focusPrimary Areas of Focus
/en/about/elements-of-astellas...Elements of Astellas’ Global Ethics & Compliance Program
/en/about/enhancing-and-sustai...Enhancing and Sustaining an Ethical and Compliant Culture at Astellas
/en/about/astellas-compliance-...Astellas awarded Compliance Leader Verification™
/en/innovationInnovation
/en/innovationInnovation We pursue cutting-edge science to continuously provide innovative treatment options. Read More
/en/innovation/rd-strategyR＆D Strategy
/en/innovation/drug-researchDrug Research
/en/innovation/pipelineMajor Pipeline
/en/innovation/clinical-trialsClinical Trials
/en/innovation/investigator-sp...Investigator Sponsored Research
/en/innovation/grants-for-educ...Grants for Education and General Research
/en/innovation/grants-for-educ...Grants to HCOs to Support HCP Attendance at Congresses
/en/innovation/areas-of-interestAreas of Interest
/en/innovation/primary-focus-g...Genetic Regulation
/en/innovation/primary-focus-i...Immuno-Oncology
/en/innovation/primary-focus-b...Blindness & Regeneration
/en/innovation/primary-focus-t...Targeted Protein Degradation
/en/innovation/primary-focus-c...Immune Homeostasis
/en/innovation/exploratory-res...Bispecific Immune Cell Engager
/en/innovation/engineered-phag...Engineered Phage Therapy
/en/innovation/direct-reprogra...Direct Reprogramming
/en/innovation/innate-immune-r...Innate Immune Regulation
/en/innovation/circadian-rhyth...Circadian Rhythm Regulation
/en/innovation/cell-therapyCell Therapy
/en/innovation/digital-transfo...Digital Transformation
/en/innovation/dx-initiatives-...DX Initiatives Throughout the Value Chain
/en/innovation/data-informatio...Data, Information and Advanced Analytics
/en/innovation/rx-plusNew Healthcare Solutions Beyond Medicine (Rx+®)
/en/innovation/leading-programsLeading Programs
/en/innovation/investigational...Investigational Near-Infrared Fluorescence Imaging Agent
/en/innovation/clinically-rele...Clinically Relevant Holistic Solutions Mobile Healthcare Application
/en/innovation/new_digital_the...New Digital Solution for Heart Failure Patients on the Horizon
/en/innovation/open-innovationOpen Innovation in Drug Discovery Research
/en/innovation/open-innovation...Our Philosophy of Open Innovation
/en/innovation/open-innovation...SakuLab-Tsukuba
/en/innovation/open-innovation...TME iLab
/en/innovation/open-innovation...SakuLab-Cambridge MA
/en/partneringSubdomain Partnering
/en/investorsInvestors
/en/investorsInvestor Relations You can access to IR related information including IR Library, Financial Information, Corporate Strategic Plan. Read More
/en/investors/strategic-planCorporate Strategic Plan 2021
/en/investors/integrated-reportIntegrated Report
/en/investors/integrated-repor...Archives
/en/investors/astellas-esg-ini...Astellas’ ESG Initiatives
/en/investors/enhancementAction to Implement Management that is Conscious of Cost of Capital and Stock Price
/en/investors/financial-inform...Financial Information
/en/investors/ir-libraryIR Library
/en/investors/ir-library/busin...Business Results
/en/investors/ir-library/pipelineOverview of R&D Pipeline
/en/investors/ir-library/ir-me...IR Meetings
/en/investors/consolidated-fin...Consolidated Financial Statements and Footnotes
/en/about/governanceText duplicate Corporate Governance Materials
/en/investors/ir-calendarIR Calendar
/en/investors/stock-rating-inf...Stock & Rating Information
/en/investors/shareholders-mee...Shareholders Meeting
/en/investors/shareholder-returnShareholder Return
/en/investors/current-share-st...Current Share Status
/en/investors/chartChart
/en/investors/ratingsIssuer Rating
/en/investors/analyst-coverageAnalyst Coverage
/en/investors/cautionary-state...Cautionary Statement
/en/investors/individual-inves...Introducing Astellas to Individual Investors
/en/sustainabilitySustainability
/en/sustainability/sustainabil...Sustainability Direction We have set Med-term Priorities, Initiatives, and Our Commitments by FY2025 as for Two pillars and Environmental Sustainability. Rea...
/en/sustainability/our-approachMessage from CEO
/en/sustainability/sustainabil...Sustainability Approach
/en/sustainability/astellas-su...Sustainability Governance
/en/sustainability/materialityKey Issues and Materiality
/en/sustainability/sustainabil...Sustainability Direction
/en/sustainability/sdpisSustainability Direction Performance Indicators (SDPIs)
/en/sustainability/iso26000ISO26000
/en/sustainability/un-developm...Astellas’ SDG Initiatives
/en/sustainability/united-nati...United Nations Global Compact
/en/sustainability/stakeholder...Stakeholder Communications
/en/sustainability/awards-and-...Awards & Recognition
/en/sustainability/access-to-h...Access to Health
/en/sustainability/access-to-h...Access to Health of Astellas
/en/sustainability/access-to-m...Access to Medicines
/en/sustainability/initiatives...Initiatives in Tanzania
/en/sustainability/strengtheni...Healthcare Systems Strengthening
/en/sustainability/program-in-...Program in Mexico
/en/sustainability/program-in-...Program in Dominican Republic
/en/sustainability/program-in-...Program in Peru
/en/sustainability/program-in-...Program in Malaysia
/en/sustainability/development...Development for Schistosomiasis
/en/sustainability/research-ac...Research Activity on Malaria
/en/sustainability/research-ac...Research Activities on NTDs
/en/sustainability/astellas-he...Astellas Healthcare E-city
/en/sustainability/ghit-fundGHIT Fund
/en/sustainability/enrich-the-...Patient Support Activity
/en/sustainability/sustainable...Working together to bring “medical-eco” activities to drug discovery in Japan
/en/sustainability/cncCommitment to healthcare for local communities
/en/sustainability/project-com...Activities of "Project Commune" in FY 2023
/en/sustainability/project-com...Activities of "Project Commune" in FY 2024
/en/sustainability/advancement...Medical Science Advancement
/en/sustainability/astellas-gl...Astellas Global Health Foundation
/en/sustainability/access-to-m...Access to Medicine Index Report
/en/sustainability/environmentEnvironment
/en/sustainability/initiatives...Environment Initiatives
/en/sustainability/environment...EHS Management
/en/sustainability/status-of-o...ISO certification status of Astellas production sites
/en/sustainability/environment...Environmental Action Plan and Compliance
/en/sustainability/measures-to...Climate Change Measures
/en/sustainability/scope-3-emi...Scope 3 emissions (past 3 years)
/en/sustainability/TCFD-disclo...Disclosure based on TCFD
/en/sustainability/breakdown-o...Energy Consumption
/en/sustainability/preserving-...Sustainable Biodiversity
/en/sustainability/preserving-...Biodiversity and Astellas An Enlarged Version
/en/sustainability/the-biodive...The Biodiversity Burden Index and Revenue
/en/sustainability/initiatives...Resource Recycling
/en/sustainability/initiatives...Preventing Pollution
/en/sustainability/further-inf...Further information on PRTR system
/en/sustainability/environment...Environmental Impact of Products and Countermeasures
/en/sustainability/environment...Archive (EHS Report)
/en/sustainability/environment...Environmental Accounting
/en/sustainability/environment...Environment-related Investments and Expenses
/en/sustainability/reporting-c...Reporting coverage, methods
/en/sustainability/socialAstellas and Society
/en/sustainability/our-peopleOur People
/en/sustainability/hr-visionHR Vision, Talent and Organization Management
/en/sustainability/diversity-m...Engagement and Diversity, Equity & Inclusion
/en/sustainability/a-living-wageA living wage
/en/sustainability/occupationa...Occupational Health & Safety
/en/sustainability/promoting-h...Promoting Health Management
/en/sustainability/major-progr...Major Activities and Programs (Japan)
/en/sustainability/sustainabil...Sustainability in Business Practice
/en/sustainability/sustainable...Sustainable Procurement Initiatives
/en/sustainability/research-in...Research Initiatives
/en/sustainability/clinical-de...Clinical Development Initiatives
/en/sustainability/technologic...Technological Development and Production Initiatives
/en/sustainability/distributio...Distribution and Sales Initiatives
/en/sustainability/respect-for...Respect for Human Rights
/en/sustainability/community-e...Community Engagement
/en/sustainability/flyingstarFlying Star Fund
/en/sustainability/changing-to...Employee Contributions to the Local Community
/en/sustainability/governanceGovernance
/en/sustainability/esgESG Data
/en/sustainability/esg-environ...ESG Data Environment
/en/sustainability/esg-socialESG Data Social
/en/sustainability/esg-governanceESG Data Governance
/en/newsroomNews
/en/newsroomNews Room Check the latest news and our people's stories. Read More
https://www.astellas.com/en/newsALL News
/en/storiesOUR STORIES
/en/newsroom/media-libraryMedia Library
/en/partneringText duplicate Partnering
/en/partnering/partnershipWhy Partner with Astellas
/en/partnering/partnering-teamsPartnering Teams
/en/partnering/testimonies-fro...Testimonies from our Partners
/en/partnering/register-formRegistration Form
/en/careers-at-astellasCareers
/en/suppliersSuppliers
/en/contact-usContact Us
https://www.astellas.com/enIMPORTANT NOTICE
/en/worldwideWORLDWIDE
https://www.astellas.com/enGLOBAL
https://www.astellas.com/jp日本
https://www.astellas.com/Cancel
https://www.astellas.com/New window Click here to leave this site.
/en/system/files/8ddc22a762/as...Subdomain Integrated Report 2024 Please check the latest Integrated Report. View more
/en/stories/leading_the_charge...Leading the Charge in Oncology Chief Medical Officer Tadaaki Taniguchi shares insights on how Astellas is advancing oncology with next-generation modalities....
IMG-ALT Leading the Charge in Oncology
/en/investors/ir-library/busin...Financial Results for Q1/FY2024 We announced our financial results for Q1/FY2024 on August 1st. Presentation material, video, and meeting script are availabl...
IMG-ALT Financial Results for Q1/FY2024
/en/about/messageFrom the CEO I will make every effort to navigate Astellas with speed and a sense of urgency that “our patients are waiting.” Read more
IMG-ALT From the CEO
/en/news/29471Oct 04, 2024General News Integrated Report 2024 is now available.
/en/news/29466Oct 02, 2024Stories Leading the Charge in Oncology: How Astellas is Redefining Cancer Treatment
/en/news/29451Sep 24, 2024Press Releases Japan’s Ministry of Health, Labour and Welfare Approves PADCEVTM (enfortumab vedotin) with KEYTRUDA® (pembrolizumab) for First-Lin...
https://www.astellas.com/en/newsEXPLORE ALL NEWS
https://www.astellas.com/en/aboutAbout us Astellas aims to stand on the forefront of healthcare change to turn innovative science into VALUE for patients. Read more
IMG-ALT About us
/en/innovation/rd-strategyR & D Strategy Astellas’ Focus Area approach supports our commitment to continuous innovation and the creation of innovative therapies that directly address ...
IMG-ALT R & D Strategy
/en/sustainabilitySustainability We are developing a sustainable society by leveraging Astellas’ strengths and capabilities. Read more
IMG-ALT Astellas and Sustainability
/en/partneringPartnering with Astellas We are actively seeking collaboration opportunities with external partners. Read More
/en/careers-at-astellasText duplicate Careers
/en/investorsInvestor Relations Read More
IMG-ALT Investor Relations
https://www.linkedin.com/compa...External Subdomain Astellas Pharma’s official LinkedIn We share the latest information and topics. Follow us
IMG-ALT LinkedIn
/en/sustainability/respect-for...Modern Slavery Act 2015
/en/contact-r-and-d-programsSubdomain Contact for Potential Acquisition of Astellas’ R＆D programs.
https://www.linkedin.com/compa...New window External Subdomain IMG-ALT Linkedin Logo
https://www.youtube.com/user/a...New window External Subdomain IMG-ALT Youtube Logo
/en/global-linkedin-community-...Global LinkedIn Community Guidelines
A-TITLE Global LinkedIn Community Guidelines
/en/sitemapSITE MAP
/en/privacy-noticePRIVACY NOTICE
/en/cookies-policyCOOKIES POLICY
/en/accessibilityACCESSIBILITY
/en/terms-of-useTERMS OF USE
/en/contact-usCONTACT US
https://www4.bcportal.jp/astel...External Subdomain DISASTER INFORMATION FOR EMPLOYEES

Server configuration

HTTP redirects
(Critically important)
This page redirects to "https://www.astellas.com/en/"
HTTP header
(Important)
No X-Powered HTTP header is sent.
This page uses GZip for compressed data transmission.
Performance
(Somewhat important)
The page response time is very slow (1.86 seconds). The response time should be less than 0.4 seconds. Slow websites are bad for search engine bots and also result in bad user experience.
The file size of the HTML document is fine (85 kB).

HTTP Response Header

NameValue
dateSun, 06 Oct 2024 06:42:04 GMT
content-typetext/html; charset=UTF-8
expiresSun, 19 Nov 1978 05:00:00 GMT
cache-controlmax-age=3600, public
varyCookie
x-drupal-dynamic-cacheUNCACHEABLE
content-languageen
x-content-type-optionsnosniff
x-frame-optionsSAMEORIGIN
last-modifiedFri, 04 Oct 2024 07:53:11 GMT
x-generatorDrupal 10 (https://www.drupal.org)
content-security-policydefault-src https: 'self' wss:; script-src https: 'unsafe-inline' 'unsafe-eval' 'self'; object-src 'self' sw4503.swcms.net; style-src https: 'unsafe-inline' 'self'; img-src https: data: www.astellas.com lh6.googleusercontent.com www.sto.ch 'self'; media-src * blob:; frame-src 'self' vars.hotjar.com sw4503.swcms.net www.google.com consentcdn.cookiebot.com www.googletagmanager.com www.youtube-nocookie.com www.youtube.com asia.tools.euroland.com player.vimeo.com login.doccheck.com w.soundcloud.com dreambroker.com td.doubleclick.net online.flippingbook.com; child-src 'self' blob: vars.hotjar.com sw4503.swcms.net www.google.com consentcdn.cookiebot.com www.googletagmanager.com www.youtube-nocookie.com www.youtube.com asia.tools.euroland.com player.vimeo.com login.doccheck.com w.soundcloud.com dreambroker.com td.doubleclick.net; font-src https: 'self' data:; report-uri /report-csp-violation
x-xss-protection1; mode=block
strict-transport-securitymax-age=1000
referrer-policystrict-origin-when-cross-origin
x-drupal-cacheMISS
x-request-idv-b428ce16-8225-11ef-af7e-0bf873a3b563
x-ah-environment01live
age2638
viavarnish
x-cacheHIT
x-cache-hits355
cf-cache-statusDYNAMIC
servercloudflare
cf-ray8ce3ab524bd071d3-FRA
content-encodinggzip
statuscode200
http_versionHTTP/2

External factors

This page is referenced by wikipedia.
This website has excellent links from other websites.
This page has backlinks from 459 referring domains.
This page has 4,064 backlinks.
This page has backlinks from 402 different ip addresses.

Links from Wikipedia

You can find more links using Wikipedia search

Robots.txt

#
# robots.txt
#
# This file is to prevent the crawling and indexing of certain parts
# of your site by web crawlers and spiders run by sites like Yahoo!
# and Google. By telling these "robots" where not to go on your site,
# you save bandwidth and server resources.
#
# This file will be ignored unless it is at the root of your host:
# Used:    http://example.com/robots.txt
# Ignored: http://example.com/site/robots.txt
#
# For more information about the robots.txt standard, see:
# http://www.robotstxt.org/robotstxt.html

User-agent: *
# CSS, JS, Images
Allow: /core/*.css$
Allow: /core/*.css?
Allow: /core/*.js$
Allow: /core/*.js?
Allow: /core/*.gif
Allow: /core/*.jpg
Allow: /core/*.jpeg
Allow: /core/*.png
Allow: /core/*.svg
Allow: /profiles/*.css$
Allow: /profiles/*.css?
Allow: /profiles/*.js$
Allow: /profiles/*.js?
Allow: /profiles/*.gif
Allow: /profiles/*.jpg
Allow: /profiles/*.jpeg
Allow: /profiles/*.png
Allow: /profiles/*.svg
# Directories
Disallow: /core/
Disallow: /profiles/
# Files
Disallow: /README.txt
Disallow: /web.config
Disallow: /sites/all/themes/astellas/js/astellas-popup.js
# Paths (clean URLs)
Disallow: /admin/
Disallow: /comment/reply/
Disallow: /filter/tips
Disallow: /node/add/
Disallow: /search/
Disallow: /user/register/
Disallow: /user/password/
Disallow: /user/login/
Disallow: /user/logout/
# Paths (no clean URLs)
Disallow: /index.php/admin/
Disallow: /index.php/comment/reply/
Disallow: /index.php/filter/tips
Disallow: /index.php/node/add/
Disallow: /index.php/search/
Disallow: /index.php/user/password/
Disallow: /index.php/user/register/
Disallow: /index.php/user/login/
Disallow: /index.php/user/logout/
# Disallow indexing of the entire SMPC backend
Disallow: /de/system/files/smpc/*
Disallow: /me/system/files/smpc/*
Disallow: /de/system/files/hcp/*
Disallow: /ch/system/files/hcp/*
Disallow: /ch/*/system/files/hcp/*
Disallow: /pl/system/files/privatefile/*
Disallow: /eu/system/files/c2p_astellas_sccs.0223_.pdf
Disallow: /system/files/astellas_sustainability_emailsignature_logo.jpg
Disallow: /system/files/astellas_sustainability_emailsignature_missionvision.jpg
Disallow: /me/system/files/pre-approved_global_congress_list_2023.pdf
Disallow: /br/system/files/mini-393186-xta-bra_xtandi_set_2023.pdf
Disallow: /en/system/files/privatefile/*
Disallow: /jp/system/files/privatefile/*
Disallow: /system/files/privatefile/*
Sitemap: https://www.astellas.com/sitemap.xml

Similar sites

Search preview

www.astellas.com
Astellas Home page | Astellas Pharma Inc.
Astellas Pharma Inc., based in Tokyo, Japan, is a company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products.

Most important keywords

Following keywords were found. You can check the keyword optimization of this page for each keyword.

KeywordResultRecheck
Astellas77%Check
Astellas Pharma73%Check
Astellas Pharma Inc70%Check
Inc60%Check
Astellas Global57%Check
Health46%Check
Products46%Check
innovative46%Check
Japan46%Check
VISION46%Check
Show more keywords and terms

Test up to 1.000 webpages of astellas.com with our free plan!

Try For Free
No trial. It's just free!

Cookie Policy

We use cookies to make our site work and also for analytics and advertising purposes. You can enable or disable optional cookies as desired. See the following links for more information.

Contact | Privacy

We need these so the site can function properly

So we can better understand how visitors use our website

So we can serve you tailored ads and promotions